Trials / Conditions / Stage IV Bladder Urothelial Carcinoma
Stage IV Bladder Urothelial Carcinoma
6 registered clinical trials studyying Stage IV Bladder Urothelial Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors NCT02717156 | University of Southern California | Phase 2 |
| Withdrawn | Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer NCT02944357 | Mayo Clinic | N/A |
| Withdrawn | Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treat NCT02718742 | Mayo Clinic | Phase 2 |
| Terminated | Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder NCT02494635 | University of Southern California | — |
| Completed | Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer NCT02437370 | University of California, Davis | Phase 1 |
| Completed | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820 | Roswell Park Cancer Institute | Phase 1 |